mac

CNS Pharmaceuticals Development Partner, WPD Pharmaceuticals, Reports Active Compound in Licensed Drug Candidate Reduces COVID19 Replication in Vitro by 100%

CNS Pharmaceuticals Development Partner, WPD Pharmaceuticals, Reports Active Compound in Licensed Drug Candidate Reduces COVID19 Replication in Vitro by 100%

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) in collaboration with its development partner WPD Pharmaceuticals Inc. intends to develop several preclinical drug candidates including WP1122, which will be tested on a range of viruses including the co..

AbbVie Announces Fourth Quarter and Full Year Financials

AbbVie Announces Fourth Quarter and Full Year Financials

AbbVie Inc. (NYSE: ABBV) announced Friday financial results for the fourth quarter and full year ended December 31, 2019. Shares of the Company spiked more than 5% Friday morning.Highlights from the report include worldwide net revenues were $8..

Macy’s Holiday Season Sales Results Give Investors Hope

Macy’s Holiday Season Sales Results Give Investors Hope

Macy’s, Inc. (NYSE: M) announced Wednesday comparable sales results for the months of November and December 2019.November/December 2019 Comparable Sales:November/December 2019Comparable sales (owned)(0.7)%Comparable sales (owned plus lice..